methacholine chloride has been researched along with Scleroderma, Systemic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bajocchi, G; Govoni, M; La Corte, R; Potena, A; Trotta, F | 1 |
Freedman, RR; Girgis, R; Mayes, MD | 2 |
3 other study(ies) available for methacholine chloride and Scleroderma, Systemic
Article | Year |
---|---|
Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjögren's syndrome.
Topics: Bronchi; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Forced Expiratory Volume; Humans; Methacholine Chloride; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Scleroderma, Systemic; Sjogren's Syndrome | 1995 |
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
Topics: Adrenergic Agonists; Clonidine; Endothelium, Vascular; Female; Humans; Male; Methacholine Chloride; Middle Aged; Raynaud Disease; Receptors, Adrenergic; Scleroderma, Systemic; Vasodilation; Vasodilator Agents | 1999 |
Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
Topics: Blood Flow Velocity; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fingers; Humans; Male; Methacholine Chloride; Muscarinic Agonists; Nitroprusside; Raynaud Disease; Scleroderma, Systemic; Substance P; Vasodilator Agents | 2001 |